Get the Stockscreener App
15.88
3.12%
0.48
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $15.88, with a volume of 291.19K.
It is up +3.12% in the last 24 hours and up +15.75% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$15.40
Open:
$15.41
24h Volume:
291.19K
Relative Volume:
0.24
Market Cap:
$730.91M
Revenue:
$203.27M
Net Income/Loss:
$-4.66M
P/E Ratio:
-158.80
EPS:
-0.1
Net Cash Flow:
$3.47M
1W Performance:
-1.61%
1M Performance:
+15.75%
6M Performance:
-12.79%
1Y Performance:
+19.85%
1-Day Range:
$15.41
$16.02
1-Week Range:
$15.24
$16.26
52-Week Range:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
15.88 | 708.59M | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
133.26 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.03 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.94 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.97 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Statistical indicators supporting Axogen Inc.’s strengthJuly 2025 Decliners & Weekly Market Pulse Updates - Newser
Top chart patterns to watch in Axogen Inc.Weekly Profit Analysis & Weekly Market Pulse Alerts - Newser
What are the analyst revisions for ENTXIs Axogen Inc. stock a good investment in YEARWeekly Risk Summary & Weekly Return Optimization Alerts - khodrobank.com
Can technical indicators confirm Axogen Inc.’s reversalJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser
Can Axogen Inc. hit a new high this monthJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Is Axogen Inc. still worth holding after the dip2025 Macro Impact & Weekly Chart Analysis and Guides - Newser
Signal strength of Axogen Inc. stock in tech scanners2025 Geopolitical Influence & Stepwise Swing Trade Plans - Newser
Can Axogen Inc. sustain earnings growthWeekly Trend Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
How sensitive is Axogen Inc. to inflationJobs Report & Risk Managed Investment Signals - khodrobank.com
Levi & Korsinsky Investigates Axogen, Inc. (AXGN) Over Potential Securities Fraud Allegations - ACCESS Newswire
Is Axogen Inc. likely to announce a buybackQuarterly Earnings Report & Fast Gaining Stock Reports - khodrobank.com
ATTENTION Axogen, Inc. (AXGN) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Developing predictive dashboards with Axogen Inc. dataQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser
What are Axogen Inc.’s recent SEC filings showingQuarterly Portfolio Summary & Technical Buy Zone Confirmation - khodrobank.com
Will Axogen Inc. outperform its industry peersWeekly Trend Recap & High Accuracy Investment Entry Signals - khodrobank.com
Axogen Inc.’s volatility index tracking explainedIndex Update & Free Growth Oriented Trading Recommendations - Newser
Historical volatility pattern of Axogen Inc. visualized2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
What chart patterns are forming on Axogen Inc.Earnings Growth Report & Weekly Setup with ROI Potential - khodrobank.com
What does recent volatility data suggest for Axogen Inc.Quarterly Trade Report & Precise Buy Zone Tips - Newser
Real time scanner hits for Axogen Inc. explainedBreakout Watch & Step-by-Step Swing Trade Plans - Newser
Key metrics from Axogen Inc.’s quarterly data2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser
What high frequency data says about Axogen Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Can Axogen Inc. weather a recessionRate Hike & Weekly Breakout Opportunity Watchlist - khodrobank.com
Is Axogen Inc. a candidate for recovery playWeekly Profit Recap & Capital Efficiency Focused Ideas - Newser
Can Axogen Inc. grow without external fundingJuly 2025 Levels & Growth Focused Stock Reports - khodrobank.com
Sector ETF performance correlation with Axogen Inc.Portfolio Return Report & Smart Allocation Stock Tips - Newser
What is the earnings history of Axogen Inc.Watch List & Consistent Income Trade Recommendations - khodrobank.com
Technical signs of recovery in Axogen Inc.2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
What data driven models say about Axogen Inc.’s futureTrade Exit Summary & Weekly Breakout Watchlists - Newser
Price momentum metrics for Axogen Inc. explainedTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Analyzing Axogen Inc. with risk reward ratio chartsEarnings Risk Summary & Weekly Top Gainers Alerts - Newser
Axogen Inc. Stock Approaches Key Moving AveragePortfolio Performance Summary & Fast Moving Market Watchlists - beatles.ru
What does recent volatility data suggest for Axogen IncStop Loss & Long-Term Growth Stock Strategies - Newser
Published on: 2025-08-31 19:47:00 - Newser
Why Axogen Inc. stock attracts strong analyst attentionProduct Launch & Reliable Price Action Trade Plans - Newser
Building trade automation scripts for Axogen Inc.Bond Market & Risk Controlled Swing Trade Alerts - Newser
How high can Axogen Inc. stock goQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Will Axogen Inc. bounce back from current supportQuarterly Portfolio Review & Consistent Growth Equity Picks - Newser
Institutional Ownership and Strategic Influence in Axogen, Inc. (NASDAQ:AXGN): A Double-Edged Sword for Shareholders - AInvest
Axogen's Ownership Structure: Institutional Dominance and Insider Sales - AInvest
With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - uk.finance.yahoo.com
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Axogen Inc Stock (AXGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
| Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
| Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
| NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
| JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
0.54%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):